Ion Channels as Therapeutic Targets: A Drug Discovery Perspective | Journal of Medicinal Chemistry
Catalysts | Free Full-Text | Biocatalysis as Useful Tool in Asymmetric Synthesis: An Assessment of Recently Granted Patents (2014–2019)
Polymeric particle-based therapies for acute inflammatory diseases | Nature Reviews Materials
Frontiers | The multifaceted roles of NLRP3-modulating proteins in virus infection
Sustainability | Free Full-Text | A Patent Bibliometric Analysis of Carbon Capture, Utilization, and Storage (CCUS) Technology
Phase 0/microdosing approaches: time for mainstream application in drug development? | Nature Reviews Drug Discovery
Advances in Antiviral Material Development - Liang - 2020 - ChemPlusChem - Wiley Online Library
In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction | Scientific Reports
Full article: Emerging PEGylated non-biologic drugs
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules | Journal of Medicinal Chemistry
An αv‐RGD Integrin Inhibitor Toolbox: Drug Discovery Insight, Challenges and Opportunities - Hatley - 2018 - Angewandte Chemie International Edition - Wiley Online Library
Non-invasive delivery strategies for biologics | Nature Reviews Drug Discovery
Recent advances in therapeutic chalcones: Expert Opinion on Therapeutic Patents: Vol 14, No 12
![Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...](https://pubs.acs.org/cms/10.1021/jm0490641/asset/images/large/jm0490641n00001.jpeg "Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...")
Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4 ...
Towards a generic prototyping approach for therapeutically-relevant peptides and proteins in a cell-free translation system | Nature Communications
IJMS | Free Full-Text | To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Pharmaceutics | Free Full-Text | Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
Frontiers | GAPDH in neuroblastoma: Functions in metabolism and survival
